Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study's Locations section was expanded and reorganized to include many additional sites across the US, Canada, Europe, Australia, and other regions. The previous grouped location entries (e.g., California Locations, District of Columbia Locations, etc.) have been removed or consolidated into a global list.SummaryDifference4%

- Check59 days agoChange DetectedPublications are now described as voluntarily provided by the submitter and may be auto-filled from PubMed, with entries that may not pertain to the study. A revision tag shows Revision: v3.3.2.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page removes a general government funding status notice that warned information may not be up to date and described NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page shows cosmetic layout updates and small textual/date edits, and no changes to the study design, outcomes, or participant criteria—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check110 days agoChange DetectedUpdated the main citation to a newer version (v3.2.0) and added a government-operating-status notice; removed an older online-ahead-of-print citation (v3.1.0).SummaryDifference2%

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.